This mendelian randomization study demonstrates causal associations between blood cell perturbation responses and lung cancer, identifying distinct protective (e.g., RET responses) and risk-associated phenotypes (e.g., RBC responses) across subtypes. The gene discussed is RET; the disease is lung carcinoma.